LXRs also regulate the expression of angiopoietin-like protein 3 (Angptl3), leading to hypertriglyceridemia via inhibition of LPL activity and activation of lipolysis in adipocytes [95–97]. The gene discussed is ANGPTL3; the disease is hypertriglyceridemia.